Parenteral anticoagulants prevent the formation of which product as the final step of clotting?

Hematoma under the skin
Hematoma is a collection of blood under the skin. This is an adverse reaction and may indicate that activated partial thromboplastin time (aPTT) values are highly elevated. The health care provider should be notified for any bleeding. Reversal drugs, such as protamine sulfate, may need to be given.

Blood in the urine
Blood in the urine is an adverse effect of heparin therapy and may indicate that aPTT values are highly elevated. The health care provider should be notified for any bleeding. Reversal drugs, such as protamine sulfate, may need to be given

Bleeding from the gum
Bleeding from the gums is an adverse effect of heparin therapy and may indicate that aPTT values are highly elevated. The health care provider should be notified for any bleeding. Reversal drugs, such as protamine sulfate, may need to be given.

Chills and fever
Chills and fever are indications for possible infection or hypersensitivity reactions. Heparin may need to be discontinued. The health care provider must be notified.

Which is a parenteral anticoagulant?

The indirect parenteral anticoagulants in current use include heparin, low-molecular-weight-heparins (LMWHs), fondaparinux, and danaparoid.

When do you use parenteral anticoagulants?

Parenteral anticoagulants—unfractionated and low-molecular-weight heparin—primarily are used to prevent and treat VTE (deep vein thrombosis [DVT] and pulmonary embolism [PE]) associated with medical conditions such as atrial fibrillation, heart disease, and atherosclerosis; they're also used to prevent clotting during ...

How do anticoagulants inhibit clot formation?

anticoagulant, any drug that, when added to blood, prevents it from clotting. Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood.

Which anticoagulant is used to prevent intravascular clotting?

Heparin can be used in vivo (by injection), and also in vitro to prevent blood or plasma clotting in or on medical devices.